Astrazeneca gets approval to use anti-diabetes drug for kidney disease : Bulletin: Business Today
Business Today

Astrazeneca gets approval to use anti-diabetes drug for kidney disease

Loading the player...

Rashi Bisaria | February 9, 2021

Bitcoin crosses $44,000 mark on $1.5 billion boost from Tesla

Bitcoin breached the $44,000 mark for the first time on Monday after Tesla revealed that it had invested around $1.5 billion in the cryptocurrency last month. The digital currency surged over 15 per cent after Elon Musk-led electric car manufacturer said that it is expected to begin accepting payment for its cars and other products with it in the near future.

PM Modi dials Joe Biden, discusses regional, climate change issues

Prime Minister Narendra Modi on Monday called newly elected US President Joe Biden and the two leaders discussed regional, environmental, and other issues. The two leaders agreed to work together to fight against the COVID-19 pandemic, rebuild the global economy that benefits the people of both countries, and stand together against the scourge of global terrorism, the White House in an official statement said.

Uttarakhand glacier burst: Locals raised concerns about hydel project 2 years ago

The residents of Raini village of Chamoli in Uttarakhand had filed a public interest litigation (PIL) in Uttarakhand High Court in 2019 on the environmental impact of Rishi Ganga hydel project. The breaking away of a Nanda Devi glacier near Raini on Sunday caused massive flooding, and the entire hydro project was washed away in the floods. Based on the PIL, the High Court had asked the state government to form a team to inspect the allegations in the PIL and had also stayed blasting in the project area till further orders.

PSU banks' credit growth to depend on govt capital support: Fitch

Indian state-run banks are staring at protracted weakness in their credit growth due to limited capital support from the government as well as risk aversion approach, says international ratings agency Fitch Ratings. The public sector banks' prospects for new business and revenue generation are likely to remain muted in 2021 due to moderately worse operating environment for the Indian banking sector, it said.

Astrazeneca gets approval to use anti-diabetes drug for kidney disease

Drug firm AstraZeneca India on Monday said it has received marketing authorisation to use its anti-diabetic drug dapagliflozin for the treatment of patients with chronic kidney disease (CKD). The receipt of the permission paves way for the launch of dapagliflozin tablets (10 mg) in the country to treat CKD, the company said in a statement. The study results of dapagliflozin showed significant benefits in reducing CKD progression in patients with and without type-2 diabetes.

More from this section